Two plants, one brew, and an experience that consistently produces what clinical psychology considers impossible: permanent personality change in a single session. The Shipibo-Conibo people of the Peruvian Amazon have worked with ayahuasca for centuries. The rest of the world discovered it in the last fifty years, misunderstood it in the next twenty, and is only now beginning — through careful science and respectful engagement with indigenous knowledge — to grasp what it actually is.
Ayahuasca is a decoction of two plants that should not, by any pharmacological logic, work together — and yet do, with a precision that suggests the knowledge of their combination was not discovered by accident. Banisteriopsis caapi, the ayahuasca vine ("vine of the soul"), contains beta-carboline alkaloids (harmine, harmaline, tetrahydroharmine) that act as monoamine oxidase inhibitors. Psychotria viridis (chacruna) contains N,N-dimethyltryptamine — DMT — which is orally inactive on its own because the body's MAO enzymes break it down before it reaches the brain.
The vine inhibits those enzymes. The leaf provides the DMT. The combination produces an orally active psychedelic experience of four to six hours, with the vine's own alkaloids adding their own dimension — a quality of slow, deep movement and bodily awareness that distinguishes ayahuasca from synthetic DMT entirely. Indigenous peoples arrived at this combination from among the thousands of plant species in the Amazon rainforest. When anthropologists asked how, the consistent answer was: the plants told us.
The chemistry is not the medicine. Western analysis isolates the active alkaloids, produces synthetic versions, and calls them equivalent. Indigenous practitioners consistently maintain the distinction: the vine is a teacher, an intelligence, a spirit — not a delivery mechanism for molecules. The growing scientific evidence for ayahuasca's therapeutic effects has been produced almost entirely using the traditional brew, not its synthetic analogues, and the ceremonial container appears to be part of what makes it work. Both frames — biochemical and traditional — describe real phenomena. The question of which frame is more complete is still open.
The Shipibo-Conibo people of the Ucayali River basin are the tradition most associated with ayahuasca in the global imagination — and their system is extraordinarily sophisticated. At its centre is the curandero (healer), who has typically spent years in isolated study under a master, following a strict dieta (the protocol of dietary restriction, celibacy and silence that prepares the body to receive plant teachings) and working with a sequence of plants that teach progressively deeper dimensions of healing knowledge.
The curandero's primary tool is the icaro — a medicine song. Icaros are not composed; they are received from the plants themselves during dieta and ceremony, and they function as the primary vehicle of healing. During ceremony, the curandero sings icaros directly to the participants, to specific areas of their bodies, or to the spirits of illness — working in a dimension that the participants, in altered states, can sometimes perceive directly. The visual language of the Shipibo textile tradition — the geometric patterns (quené) that cover their clothing and artwork — is said to be the visual representation of these same songs, the patterns the plants teach made visible.
Ayahuasca has been studied in clinical settings since the early 2000s, with research accelerating dramatically in the 2010s. The findings are consistent enough to constitute a scientific story, even if the mechanism remains incompletely understood.
Depression and PTSD: multiple studies, including a 2018 randomized controlled trial published in Psychological Medicine, have found rapid and sustained antidepressant effects from single ayahuasca sessions — effects that appear within days and last weeks to months. The rapidity distinguishes it from conventional antidepressants, which require weeks to act, and the duration distinguishes it from ketamine, whose antidepressant effects fade within days. PTSD studies show similar promise, with the combination of emotional processing during ceremony and the consolidation period afterward appearing to allow trauma material to be revisited and recontextualized in ways that conventional therapy achieves more slowly.
Addiction: observational studies of participants in ayahuasca ceremonies consistently show significant reduction in problematic use of alcohol, tobacco and other substances — effects that appear to involve both increased self-awareness and a fundamental shift in one's relationship to craving. The Santo Daime and União do Vegetal churches, Brazilian religious organizations that use ayahuasca as a sacrament, have been studied for decades and show notably low rates of substance abuse among members.
Neuroplasticity: DMT and the beta-carbolines both appear to promote neuroplasticity — the brain's capacity to form new connections and reorganize existing ones. This may partly explain the lasting changes in personality and perspective that participants consistently report, and which are virtually unknown from any other single session of any kind.
Ayahuasca moved beyond Amazonia through several channels simultaneously. Brazilian syncretic religions — Santo Daime (founded 1930) and União do Vegetal (founded 1961) — incorporated ayahuasca into Christian-inflected ceremonial frameworks and eventually expanded globally, with both organizations now active in dozens of countries and holding legal religious status in Brazil, the United States and several European nations.
In the 1960s–80s, anthropologists, adventurers and eventually psychedelic researchers made contact with Amazonian traditions — most influentially Terence McKenna, whose writings about the Amazon and DMT (covered separately in this site's Figures section) brought ayahuasca to a generation of Western seekers. The 1990s and 2000s saw the emergence of "ayahuasca tourism" — seekers travelling to Peru, Brazil and Ecuador for ceremonies — and the 2010s saw ceremonies multiply in Western cities, often run by practitioners whose training was shorter and less rigorous than the tradition demands.
The appropriation question: indigenous communities have expressed consistent concern about the commercialization of ayahuasca — the use of their sacred medicine outside its cultural framework, often by non-indigenous practitioners, in contexts stripped of the dieta, the curandero's training, and the communal accountability that traditional practice maintains. The concern is not merely symbolic: documented cases of sexual abuse by "retreat operators" claiming indigenous credentials, and the financial extraction of wealth from communities that have held this knowledge for centuries, are real harms. This does not mean non-indigenous people cannot work with ayahuasca — the Brazilian religious traditions demonstrate otherwise — but it does mean that choosing a reputable, ethically grounded and appropriately trained context is not optional. It is the difference between ceremony and exploitation, of oneself and of others.
This is not a recreational experience and should not be treated as one. Ayahuasca produces some of the most intense psychological experiences a human being can have. Participants regularly encounter traumatic material, existential terror, and experiences of death and dissolution that, without appropriate preparation and support, can be profoundly destabilizing. Reported cases of people experiencing prolonged psychosis or severe psychiatric distress following ayahuasca ceremonies exist — almost always in contexts of inadequate screening, inadequate support or inadequate integration.
Medical contraindications are serious. Ayahuasca is incompatible with SSRIs, SNRIs, MAOIs and a range of other medications — the drug interaction can be life-threatening (serotonin syndrome). A history of psychosis, schizophrenia or bipolar disorder with psychotic features is a contraindication. Cardiovascular conditions require assessment. These are not bureaucratic cautions; they are genuine medical risks that a responsible ceremony provider will screen for carefully.
The science is promising, not conclusive. The therapeutic research is compelling, but most studies are small, unblinded (participants know they have taken ayahuasca) and conducted in motivated populations. The effects are real; the magnitude and generalizability are still being established. The therapeutic potential is significant; the hype sometimes exceeds the evidence.
The experience does not guarantee the insight. The most important research finding may be this: the therapeutic outcomes correlate not with the intensity of the visual experience but with the quality of emotional processing and — above all — with the integration work done in the weeks and months after ceremony. The medicine opens a door. Walking through it takes time, courage and support that no single ceremony provides.